NasdaqCM - Nasdaq Real Time Price • USD
Iterum Therapeutics plc (ITRM)
As of 1:22 PM EDT. Market Open.
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| AHRENS BRENTON KARL Director | Sale | Sep 20, 2022 | -- |
| CHIN MARK Director | Conversion of Exercise of derivative security | Jun 15, 2023 | 18,306 |
| DENNER ALEXANDER J Beneficial Owner of more than 10% of a Class of Security | Sale | Feb 12, 2021 | -- |
| DUNNE MICHAEL W Director | Purchase | Dec 22, 2023 | 113,754 |
| FISHMAN COREY N Chief Executive Officer | Purchase | Nov 20, 2023 | 54,449 |
| HECHT BETH P Director | Conversion of Exercise of derivative security | Jun 15, 2023 | 18,839 |
| HUNT RONALD M Director | Conversion of Exercise of derivative security | Sep 29, 2023 | 111,432 |
| MATTHEWS JUDITH M Chief Financial Officer | Stock Award(Grant) | Mar 10, 2023 | 8,135 |
| PUTTAGUNTA SAILAJA Officer | Conversion of Exercise of derivative security | Dec 1, 2023 | 10,369 |
| RA CAPITAL MANAGEMENT, L.P. Beneficial Owner of more than 10% of a Class of Security | Conversion of Exercise of derivative security | Feb 4, 2021 | -- |
Related Tickers
GRTX Galera Therapeutics, Inc.
0.2004
-3.42%
SYBX Synlogic, Inc.
1.8700
-1.06%
SPRO Spero Therapeutics, Inc.
1.4716
+2.91%
EIGRQ Eiger BioPharmaceuticals, Inc.
2.9500
-2.96%
LVTX LAVA Therapeutics N.V.
2.8199
+6.81%
THAR Tharimmune, Inc.
0.3656
+1.53%
MIST Milestone Pharmaceuticals Inc.
1.5969
+0.43%
NXTC NextCure, Inc.
1.3600
+5.43%
PRTC.L PureTech Health plc
218.00
+2.59%
SPRB Spruce Biosciences, Inc.
0.7016
+0.09%